Sophia Ktori

Sophia Ktori is a science journalist with a focus on infectious diseases and immunology. Her work has appeared in publications such as Genetic Engineering & Biotechnology News, where she covers the latest research and developments in these fields. In her article titled “Universal Vaccine Strategy Boosts Body’s RNAi Response to Viruses,” Ktori discusses a universal vaccine strategy that boosts the body's RNAi response to viruses, as well as the role of regulatory T cells in maintaining a healthy body and preventing autoimmunity. She also explores the research led by Salk professor Ye Zheng and assistant professor Jesse Dixon, MD, PhD, on understanding how regulatory T cells develop and work and their potential manipulation to encourage the destruction of cancer cells or prevent autoimmunity.

Biography:  https://www.genengnews.com/topics/translational-medicine/chromatin-architecture-of-treg-cells-may-offer-target-for-immunosuppressive-therapies/

70%

The overall score is a weighted number that takes into account conflict of interest, bias, deception and other practices that undermines the credibility of the source. It is calculated as:
Analysis.OverallConflictOfInterestScore * 0.3F + Analysis.OverallBiasScore * 0.3F + Analysis.DeceptivenessScore * 0.3F + Analysis.ReadabilityScore * 0.1F

A score that takes into consideration the content for flow, interruptions with ads, and overt search engine optimization techniques that makes the content hard to understand

The Daily's Verdict

This author has a mixed reputation for journalistic standards. It is advisable to fact-check, scrutinize for bias, and check for conflicts of interest before relying on the author's reporting.

Bias

0%

Examples:

No current examples available.

Conflicts of Interest

100%

Examples:

No current examples available.

Contradictions

95%

Examples:

  • The vaccine uses live, modified version of a virus and relies on small RNA molecules instead of traditional immune response or immune active proteins.

Deceptions

100%

Examples:

No current examples available.

Recent Articles

New RNA-Based Vaccine Strategies Offer Broad Protection Against Viruses like Influenza and SARS-CoV-2

New RNA-Based Vaccine Strategies Offer Broad Protection Against Viruses like Influenza and SARS-CoV-2

Broke On: Monday, 15 April 2024 Scientists at the University of California and Georgia Tech have developed RNA-based vaccine strategies that target a common part of viral genomes, potentially offering broad protection against various strains including influenza and SARS-CoV-2. These vaccines are safer for vulnerable populations, as they don't rely on traditional immune responses or active proteins. Promising results in mice experiments indicate the need for further human testing.